| Name | Title | Contact Details |
|---|
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer`s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector`s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in discovery and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
Gaiam, Inc. (Gaiam) is a lifestyle media company providing a selection of information, media, products and services to customers, who value personal development, wellness, ecological lifestyles, responsible media and conscious community.
Patient Comfort Systems is a Newark, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Park Dental Research Corp is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Integrative Emergency Services (IES) is a healthcare company that partners with Texas hospitals to provide the best patient encounter in emergency care. IES is transforming the way healthcare is practiced across the continuum of care and furthering the...